Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis

被引：0
|
作者：
Andrew Ip
Alex Mutebi
Tongsheng Wang
Monika Jun
Anupama Kalsekar
Fernando Rivas Navarro
Anthony Wang
Rajesh Kamalakar
Mariana Sacchi
Brian Elliott
机构：
[1] Hackensack University Medical Center,Hackensack Meridian Health
[2] Genmab US,undefined
[3] Inc.,undefined
[4] AbbVie,undefined
[5] Inc.,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Bispecific antibody; Chimeric antigen receptor; Immunotherapy; Observational; Real-world evidence; Retrospective; Salvage therapy; Standard of care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1226 / 1244
页数：18
相关论文
共 50 条
  • [41] Diffuse Large B-Cell Lymphoma in the Elderly: Real-World Outcomes From a Developing Country
    Jobanputra, Kunal
    Nayak, Lingaraj
    Jain, Hasmukh
    Shet, Tanuja
    Epari, Sridhar
    Bonda, V. N. Avinash
    Thorat, Jayashree
    Bagal, Bhausaheb
    Laskar, Siddhartha
    Rangarajan, Venkatesh
    Agrawal, Archi
    Gujral, Sumeet
    Khanna, Nehal
    Goda, Jayant Sastri
    Sengar, Manju
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (10): : E898 - E906
  • [42] Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
    Alduaij, Waleed
    Collinge, Brett
    Ben-Neriah, Susana
    Jiang, Aixiang
    Hilton, Laura K.
    Boyle, Merrill
    Meissner, Barbara
    Chong, Lauren
    Miyata-Takata, Tomoko
    Slack, Graham W.
    Farinha, Pedro
    Craig, Jeffrey W.
    Lytle, Andrew
    Savage, Kerry J.
    Villa, Diego
    Gerrie, Alina S.
    Freeman, Ciara L.
    Gascoyne, Randy D.
    Connors, Joseph M.
    Morin, Ryan D.
    Sehn, Laurie H.
    Mungall, Andrew J.
    Steidl, Christian
    Scott, David W.
    [J]. BLOOD, 2023, 141 (20) : 2493 - 2507
  • [43] Real World Characteristics and Outcomes of Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma; A Provincial Experience
    Manji, Farheen
    Stewart, Douglas A.
    [J]. BLOOD, 2020, 136
  • [44] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: SEER-MEDICARE ANALYSIS
    Hamlin, P.
    Satram-Hoang, S.
    Reyes, C.
    Hoang, K.
    Guduru, S.
    Skettino, S.
    [J]. HAEMATOLOGICA, 2013, 98 : 353 - 353
  • [45] Real-world outcomes of patients with relapsed/refractory large B-cell lymphoma receiving second-line therapy in England
    Fox, Christopher P.
    Townsend, William
    Gribben, John G.
    Menne, Tobias
    Kalakonda, Nagesh
    Williams, Paula
    Toron, Farah
    Tyas, Emma
    Cooper, Miranda
    Rickards, Joshua
    Radford, John
    [J]. EJHAEM, 2024,
  • [46] Healthcare Resource Utilization and Costs in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A US Real-World Observational Study
    Yang, Xiaoqin
    Laliberte, Francois
    Germain, Guillaume
    Raut, Monika
    Duh, Mei Sheng
    Sen, Shuvayu S.
    Lejeune, Dominique
    Desai, Kaushal D.
    Armand, Philippe
    [J]. BLOOD, 2019, 134
  • [47] Real-world data for lenalidomide maintenance in responding patients of diffuse large B-cell lymphoma
    Wang, Xiaoyan
    Yu, Lu
    Jiang, Xinlu
    Ding, Kaiyang
    [J]. CANCER MEDICINE, 2023, 12 (09): : 10553 - 10562
  • [48] Real World of Experience Axicabtagene Ciloleucel for The Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Spain
    Kwon, Mi
    Bailen, Rebeca
    Lopez Corral, Lucia
    Luis Reguera, Juan
    Iacoboni, Gloria
    Hernani Morales, Rafael
    Ortiz Maldonado, Valentin
    Bastos Oreiro, Mariana
    Martin Garcia, Alejandro
    Martinez Cibrian, Nuria
    Barba, Pere
    Delgado, Julio
    Jose Terol, Maria
    Diez Martin, Jose Luis
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 37 - 39
  • [49] Polatuzumab vedotin for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma
    Malecek, Mary-Kate
    Watkins, Marcus P.
    Bartlett, Nancy L.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 831 - 839
  • [50] Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?
    Mondello, Patrizia
    Steiner, Normann
    Willenbacher, Wolfgang
    Ferrero, Simone
    Ghione, Paola
    Marabese, Alessandra
    Pitini, Vincenzo
    Cuzzocrea, Salvatore
    Mian, Michael
    [J]. ONCOLOGIST, 2016, 21 (09): : 1107 - 1112
12345